CClinicalTrials.gg
Not yet recruitingNCT07617714Updated Jun 2, 2026

Adapted Physical Activity (APA) Following Hospitalization in Frail Older Adults

An interventional study of Adapted Physical Activity Program and routine care in Oncologic Disease, sponsored by Biobizkaia Health Research Institute. Not yet recruiting. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-06-02.

Sponsored by Biobizkaia Health Research Institute · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

To evaluate the effectiveness of an Adapted Physical Activity (APA) program in improving functional capacity and reducing frailty in older adults following hospital discharge.

The aim is to determine whether a structured program of personalized exercises improves mobility, strength, and quality of life compared to standard care.

02

Conditions studied

  • Oncologic Disease
03

In context

Lead sponsor

Biobizkaia Health Research Institute is the lead sponsor of 4 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • The study is open to individuals aged 65 and older.
  • Current diagnosis or recent history of cancer.
  • Patients currently undergoing treatment (chemotherapy, immunotherapy, targeted therapy) or in follow-up after recent treatment (≤12 months since completion).
  • Functional capacity compatible with participation in an adapted physical activity program, as determined by clinical assessment.
  • Recent hospitalization: Patients must have been discharged following a hospital stay.
  • Frailty: Presence of a significant level of frailty at hospital discharge.

Exclusion criteria

Exclusion Criteria:

  • Short Physical Performance Battery> 10: Patients considered "robust" are excluded to maximize the relevance of the intervention.
  • Acute unstable medical condition or contraindication to exercise: Any unstabilized acute condition that makes physical activity dangerous (e.g., acute cardiac complication, ongoing severe infection). Recent major medical events (myocardial infarction, major surgery, bone fracture, or major amputation in the past few weeks) will also be excluded.
  • Severe chronic conditions incompatible with exercise: Severe progressive diseases that prevent safe exercise, such as severe neuromuscular diseases or advanced organ failure (e.g., end-stage renal failure).
  • Short-term life-threatening prognosis: Patients in the terminal phase or with a very limited life expectancy (less than 6 months).
  • Total functional dependence or severe motor impairment: Patients who are completely dependent for basic activities (very low Barthel Index, e.g., \<20/100) or who are unable to move even minimally (e.g., unable to walk a few steps or stand, even with assistance).
  • Severe cognitive impairment: Severe cognitive impairment (e.g., advanced dementia without the ability to follow simple instructions) that prevents active participation in the program.
  • Severe sensory or communication disorders: Significant sensory impairments-such as profound uncompensated blindness or deafness-or any communication barrier (severe aphasia, language barrier) that prevents participation in the program, unless a caregiver (family member or professional) can be present to ensure safety during the exercises.
  • Institutionalization of the patient: Individuals who do not live in their usual residence are excluded. The study focuses on older adults returning home, as the institutional setting involves different care.
  • Lack of valid informed consent: Any patient who refuses to participate or who cannot provide valid consent (due to lack of legal capacity or understanding) will be excluded.
  • Participation in another concurrent program or trial: Simultaneous participation in another physical exercise program or trial.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Other
    Adapted Physical Activity Program

    Other: Adapted Physical Activity Program

  • Other
    routine care

    Other: routine care

Interventions

  • OtherAdapted Physical Activity Program

    a 14-week Adapted Physical Activity (APA) program following hospital discharge

  • Otherroutine care

    Participants in the control group will receive standard post-discharge care, along with general recommendations for physical activity and healthy lifestyle habits

06

What researchers measure

Primary outcomes

  1. Improvement in overall physical function assessed by changes in the Short Physical Performance Battery (SPPB) score."

    Time frame: 4 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07617714
Lead sponsor
Biobizkaia Health Research Institute
Responsible party
Sponsor
First posted
Jun 1, 2026
Start date
Jun 2026 (estimated)
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Jun 2, 2026

Study contacts

Elena Galve, Doctor
Contact
elena.galvecalvo@osakidetza.eus
944006000

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion